Review: Immunobiology of Preeclampsia
Corresponding Author
Dr Robert N. Taylor
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, California 94143-0556
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, CA 94143-0556.Search for more papers by this authorCorresponding Author
Dr Robert N. Taylor
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, California 94143-0556
Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, CA 94143-0556.Search for more papers by this authorAbstract
Preeclampsia has been recognized clinically since the time of Hippocrates: however its etiology and pathophysiology remain enigmatic. This pregnancy-specific syndrome typically presents in late pregnancy as hypertension, edema, and proteinuria. Investigations over the past 15 years have revealed that preeclampsia is associated with abnormal placentation, reduced placental perfusion, endothelial cell dysfunction, and systemic vasospasm. Since it occurs more commonly in Primigravidae and in women with underlying collagen-vascular diseases, an immunological component has long been suspected. Increased prevalence in high-order and molar pregnancies and those associated with increased placental mass suggests that trophoblastic volume and fetal antigen load are correlated with the syndrome. Epidemiological reports indicate that the prevalence of preeclampsia is decreased in women who received heterologous blood transfusions, practiced oral sex, or when a long period of cohabitation preceded an established pregnancy. Conversely, the use of condoms as a primary mode of contraception is associated with a higher risk of preeclampsia. These studies suggest that prior exposure to foreign or paternal antigens imparts a protection against the likelihood of developing preeclampsia. Clinical evidence of cellular and humoral immune dysfunction is associated with the syndrome. Fibrin and complement deposition and “foam” cells in atherosis lesions resemble the histopathology of renal allograft rejection. Relative T-cell, natural killer cell, and neutrophil activation have been reported in preeclampsia and circulating cytokines and antiphospholipid antibodies are more prevalent in preeclamptic than in normal pregnant women. These abnormalities are consistent with the systemic endothelial cell dysfunction that has been postulated as a pathophysiological feature of preeclampsia. While such associations do not prove causality, they suggest testable hypotheses for continued basic and clinical investigation of this major complication of human pregnancy.
REFERENCES
- 1 Roberts JM, Redman CW. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341: 1447–1451.
- 2 Sibai BM, Gordon T., Thom E., et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study: The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995; 172: 642–648.
- 3 Eastman NJ. The toxemias of pregnancy. In: Williams Obstetrics. 10th Ed. Appleton-Century-Crofts, New York, 1950.
- 4 Burrows RF, Burrows EA. The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995; 173: 929–935.
- 5 Houser MT, Fish AJ, Tagatz GE, et al. Pregnancy and systemic lupus erythematosus. Am J Obstet Gynecol 1980; 138: 409–413.
- 6 Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177–191.
- 7 Kitzmiller JL, Benirschke K. Immunofluorescent study of placental bed vessels in preeclampsia of pregnancy. Am J Obstet Gynecol 1973; 115: 248–251.
- 8 Dieckmann WJ. The toxemias of pregnancy. In: Factors influencing eclampsia in pregnant women. CV Mosby, St. Louis, 1941: 250–251.
- 9 Robillard PY, Hulsey TC, Alexander GR, et al. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. J Reprod Immunol 1993; 24: 1–12.
- 10 Klonoff-Cohen, H.S., Savitz DA, Cefalo RC et al., An epidemiologic study of contraception and preeclampsia. JAMA 1989; 262: 3143–3147.
- 11 Feeney JG, Tovey LA, Scott JS. Influence of previous blood-transfusion on incidence of pre-eclampsia. Lancet 1977; 1: 874–875.
- 12 Dekker GA. Oral tolerization to paternal antigens and preeclampsia. Am J Obstet Gynecol 1996; 174: 450.
- 13 Robillard PY, Hulsey TC, Perianin J., et al. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344: 973–975.
- 14 Feinberg BB, Gonik B. General precepts of the immunology of pregnancy. Clin Obstet Gynecol 1991; 34: 3–16.
- 15 Matthiesen L., Berg G., Ernerudh, et al. Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol 1995; 33: 31–39.
- 16 Toder V., Blank M., Gleicher N., et al. Activity of natural killer cells in normal pregnancy and edema-proteinuria-hypertension gestosis. Am J Obstet Gynecol 1983; 145: 7–10.
- 17 Greer IA, Dawes J., Johnson TA, et al. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol 1991; 78: 28–32.
- 18 Billington WD. Maternal immune response to pregnancy. Reprod Fertil Dev 1989; 1: 183–191.
- 19 Bulmer JN, Longfellow M. Leukocytes and resident blood cells in endometrium. Ann NY Acad Sci 1991; 622: 57–68.
- 20 Stites DP, Pavia CS, Clemens LE, et al. Immunologic regulation in pregnancy. Arthritis Rheumatol 1979; 22: 1300–1307.
- 21 Colbern GT, Main EK. Immunology of the maternal-placental interface in normal pregnancy. Semin Perinatol 1991; 15: 196–205.
- 22 Kovats S., Main EK, Librach C., et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220–223.
- 23 McMaster MT, Librach CL, Zhou Y., et al. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995; 154: 3771–3778.
- 24 Roberts JM, Taylor RN, Musci TJ, et al. Preeclampsia: An endothelial cell disorder Am J Obstet Gynecol 1989; 161: 1200–1204.
- 25 Khong TY, De Wolf F., Robertson WB, et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049–1059.
- 26 Pijnenborg R., Anthony J., Davey DA, et al. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648–655.
- 27 Fisher SJ, Damsky CH. Human cytotrophoblast invasion. Semin Cell Biol 1993; 4: 183–188.
- 28 De Groot CJM, O'Brien TJ, Taylor RN. Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am J Obstet Gynecol 175: 24–29, 1996.
- 29 Bower S., Schuchter K., Campbell S. Doppler ultrasound screening as part of routine antenatal scanning: prediction of pre-eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1993; 100: 989–994.
- 30 Fitzgerald DJ, Entman SS, Mulloy K., et al. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. Circulation 1987; 75: 956–963.
- 31 Remuzzi G., Marchesi D., Zoja C., et al. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 1980; 20: 105–110.
- 32 Taylor RN, Varma M., Teng NNH, et al. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab 1990; 71: 1675–1677.
- 33 Nova A., Sibai BM, Barton JR, et al. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol 1991; 165: 724–727.
- 34 Lockwood CJ, Peters JH. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990; 162: 358–362.
- 35 Taylor RN, Crombleholme WR, Friedman SA, et al. High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am J Obstet Gynecol 1991; 165(4): 895–901.
- 36 Hsu CD, Iriye B., Johnson TR, et al. Elevated circulating thrombomodulin in severe preeclampsia. Am J Obstet Gynecol 1993; 169: 148–149.
- 37 Kincaid-Smith P. Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Internat 1975; 7: 242–253.
- 38 Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. II. Mitochondrial changes. Am J Obstet Gynecol 163: 943–953.
- 39 Gant NF, Daley GL, Chand S., et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52: 2682–2689.
- 40 McCarthy AL, Woolfson RG, Raju SK, et al. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993; 168: 1323–1330.
- 41 Kahaleh MB. The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response. Clin Exp Rheumatol 1990; 8: 595–601.
- 42 Arias F., Andrinopoulos G., Zamora J. Whole-blood fibrinolytic activity in normal and hypertensive pregnancies and its relation to placental concentration of urokinase inhibitor. Am J Obstet Gynecol 1979; 133: 624–629.
- 43 Triplett DA. Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 1992; 28: 211–215.
- 44 Cutolo M., Sulli A., Seriolo B., et al. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13: 217–226.
- 45 Lim KH, Rice GE, De Groot CMJ, et al. Plasma type II phospholipase A2 levels are elevated in severe preeclampsia. Am J Obstet Gynecol 1995; 172: 998–1002.
- 46 Colbern GT, Chiang MH, Main EK. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994; 170: 1244–1250.
- 47 Lim KH, Bass K., Chun SH, et al. Differentiation of invasive cytotrophoblasts in normal and abnormal pregnancy. Soc Gynecol Invest 1994; 42: 107A.
- 48 Humphrey KE, Harrison GA, Cooper DW, et al. HLA-G deletion polymorphism and preeclampsia/eclampsia. Br J Obstet Gynaecol 1995; 102: 707–710.
- 49 Giacomini P., Tosi S., Murgia C., et al. First-trimester human trophoblast is class II major histocompatibility complex mRNA+/antigen-. Hum Immunol 1994; 39: 281–289.
- 50 Labarrere CA, Faulk WP. Intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigens are expressed on endo-vascular cytotrophoblasts in abnormal pregnancies. Am J Reprod Immunol 1995; 33: 47–53.
- 51 Rodgers GM, Taylor RN, Roberts JM. Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908–914.
- 52 Tsukimori K., Maeda H., Shingu M., et al. The possible role of endothelial cell in hypertensive disorders during pregnancy. Obstet Gynecol 1992; 80: 229–233.
- 53 Kupferminc MJ, Mullen TA, Russell TL, et al. Serum from patients with severe preeclampsia is not cytotoxic to endothelial cells. J Soc Gynecol Invest 1996; 3: 89–92.
- 54 Endresen MJ, Tosti E., Lorentzen B., et al. Sera of preeclamptic women are not cytotoxic to endothelial cells in culture. Am J Obstet Gynecol 1995; 172: 196–201.
- 55 Roberts JM, Edep ME, Goldfein A., et al. Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence. Am J Reprod Immunol 1992; 27: 101–108.
- 56 Nachman RL, Silverstein R. Hypercoagulable states. Ann Intern Med 1993; 119: 819–827.
- 57 Stricker RB, Main EK, Kronfield J., et al. Severe post-partum eclampsia: response to plasma exchange. J Clin Apheres 1992; 7: 1–3.
- 58 Rappaport VJ, Hirata G., Yap HK, et al. Anti-vascular endothelial cell antibodies in severe preeclampsia. Am J Obstet Gynecol 1990; 162: 138–146.
- 59 Branch DW. Antiphospholipid antibodies and pregnancy: Maternal implications. Semin Perinatol 1990; 14: 139–146.
- 60 Rote NS, Walter A., Lyden TW. Antiphospholipid antibodies—lobsters or red herrings Am J Reprod Immunol 1992; 28: 31–37.
- 61 Yasuda M., Takakuwa K., Tokunaga A. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995; 86: 555–559.
- 62 Carreras LO, Vermylen JG. Lupus” anticoagulant and thrombosis: Possible role of inhibition of prostacyclin formation. Thrombos Haemostas 1982; 48: 38–40.
- 63 Tannenbaum SH, Finko R., Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137: 1532–1537.
- 64 Walker TS, Triplett DA, Javed N., et al. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. Thrombos Res 1988; 51: 267–281.
- 65 De Groot CJ, Davidge S., Friedman S., et al. Plasma from preeclamptic women increases human endothelial cell prostacyclin production without changes in cellular enzyme activity or mass. Am J Obstet Gynecol 1995; 172.3: 976–985.
- 66 Branch DW, Davidge ST, Friedman SA, et al. Sera from preeclamptic patients contain factor(s) that stimulate prostacyclin production by human endothelial cells. Prost Leuko Ess Fatty Acids 1992; 45: 191–195.
- 67 Meekins JW, McLaughlin PJ, West DC, et al. Endothelial cell activation by tumour necrosis factor-alpha (TNF-alpha) and the development of pre-eclampsia. Clin Exp Immunol 1994; 98: 110–114.
- 68 Vince GS, Starkey PM, Austgulen R., et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20–25.
- 69 Kupferminc MJ, Peaceman AM, Wigton TR, et al. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170: 1752–1759.
- 70 Taylor RN, Musci TJ, Rodgers GM, et al. Preeclamptic sera stimulate increased platelet-derived growth factor mRNA and protein expression by cultured human endothelial cells. Am J Reprod Immunol 1991; 25: 105–108.
- 71 Taylor RN, Heilbron DC, Roberts JM. Growth factor activity in the blood of women in whom preeclampsia develops ###is elevated from early pregnancy. Am J Obstet Gynecol 1990; 163: 1839–1844.
- 72 Bertani T., Abbate M., Zoja C., et al. Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 1989; 134: 419–430.
- 73 Jacobson PB, Schrier DJ. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2. J Immunol 1993; 151: 5639–5652.
- 74 Pfeilschifter J., Schalkwijk C., Briner VA, et al. Cytokinestimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest 1993; 92: 2516–2523.
- 75 Jendryczko A., Drózdz M. Increased placental phospholipase A2 activities in preeclampsia. Zentralbl Gynakol 1990; 112: 889–891.
- 76 Opsjon SL, Novick D., Wathen NC, et al. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J Reprod Immunol 1995; 29: 119–134.
- 77 Domingo CG, Domenech N., Aparicio P., et al. Human pregnancy serum inhibits proliferation of T8-depleted cells and their interleukin-2 synthesis in mixed lymphocyte cultures. J Reprod Immunol 1985; 8: 97–110.
- 78 Hara N., Fujii T., Okai T., et al. Histochemical demonstration of interleukin-2 in decidua cells of patients with preeclampsia. Am J Reprod Immunol 1995; 34: 44–51.
- 79 Greer IA, Lyall F., Perera T., et al. Increased concentration of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction Obstet Gynecol 1994; 84: 937–940.
- 80 Sudo N., Kamoi K., Ishibashi M., et al. Plasma endothelin-1 and big endothelin-1 levels in women with pre-eclampsia. Acta Endocrinol (Copenh) 1993; 129: 114–120.
- 81 Benigni A., Orisio S., Gaspari F., et al. Evidence against a pathogenetic role for endothelin in pre-eclampsia. Br J Obstet Gynaecol 1992; 99: 798–802.
- 82 McMahon LP, Redman CW, Firth JD. Expression of the three endothelin genes and plasma levels of endothelin in pre-eclamptic and normal gestations. Clin Sci (Colch) 1993; 85: 417–424.
- 83 Wilkes BM, Susin M., Mento PF. Localization of endothelin-1-like immunoreactivity in human placenta. J Histochem Cytochem 1993; 41: 535–541.
- 84 Genbacev O., Joslin R., Damsky CH, et al. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996; 97: 540–550.
- 85 Wiebke JL, Montrose-Rafizadeh C., Zeitlin PL, et al. Effect of hypoxia on endothelin-1 production by pulmonary vascular endothelial cells. Biochim Biophys Acta 1992; 1134: 105–111.
- 86 Chesley LC. Hypertensive disorders in pregnancy. Appleton-Century-Crofts, New York, 1978: 777–822.
- 87 Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: Possible single gene control of preeclampsia and eclampsia and the descendants of eclamptic women. Br J Obstet Gynecol 1986; 93: 898–908.
- 88 Thornton JG, Onwude JL. Pre-eclampsia: discordance among identical twins. BMJ 1991; 303: 1241–1242.
- 89 Hayward C., Livingstone J., Holloway S., et al. An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. Am J Hum Genet 1992; 50: 749–757.
- 90 Cooper DW, Brennecke SP, Wilton AN. Genetics of pre-eclampsia. Hypertens Pregnancy. 1993; 12: 1–23.
- 91 Ward K., Hata A., Jeunemaitre X., et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993; 4: 59–61.
- 92 Arngrimsson R., Bjornsson S., Geirsson RT, et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97: 762–769.
- 93 Redman CWG. Immunology of preeclampsia. Semin Perinatol 1991; 15: 257–262.
- 94 Ober C. The maternal-fetal relationship in human pregnancy: An immunogenetic perspective. Exp Clin Immunol 1992; 9: 1–14.
- 95 Kilpatrick DC, Gibson F., Livingston J., et al. Pre-eclampsia is associated with HLA-DR4 sharing between mother and fetus. Tissue Antigens 1990; 35: 178–181.
- 96 Schneider K., Knutson F., Tamsen L., et al. HLA antigen sharing in preeclampsia. Gynecol Obstet Invest 1994; 37: 87–90.
- 97 Peterson RD, Tuck-Muller CM, Spinnato JA, et al. An HLA-haplotype associated with preeclampsia and intrauterine growth retardation. Am J Reprod Immunol 1994; 31: 177–179.
- 98 Chen G., Wilson R., Wang SH, et al. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 1996; 104: 154–159.
- 99 Sullivan CA, Magann EF, Perry KG, et al. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 1994; 171: 940–943.